Brought to you by 
Fluidigm raises $18.5mm from over a hundred investors
30 Nov 2009
Executive Summary
Fluidigm (produces integrated fluid circuits, instrumentation, and software for gene expression quantification, protein crystallization, and other applications) has grossed $18.5mm through the sale of stock to 101 investors. According to the Form D, the company could bring in an additional $5.6mm through this offering.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Nanotechnology, Chips, etc.
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Fluidigm raises $18.5mm from over a hundred investors
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice